Coventry Group Limited Reports FY25 Sales Down 1.7%, EBITDA Plummets 40.9%

Reuters
08/05
Coventry Group Limited Reports FY25 Sales Down 1.7%, EBITDA Plummets 40.9%

Coventry Group Limited (ASX: CYG) announced its FY25 trading results, reporting a decrease in group sales to $365.2 million, down 1.7% compared to the prior year. The unaudited EBITDA for the same period was $12.3 million, reflecting a significant decline of 40.9% from the previous year. This downturn was attributed to softer market conditions across Australia and New Zealand, the challenges associated with the implementation of a new ERP system, and underperformance in sales growth strategies. Despite these challenges, the company maintained strong gross margins; however, the high cost base led to poor net margin outcomes. In the Fluid Systems segment, sales declined by 7.4%, contributing to the overall decrease in consolidated group sales. Additionally, the segment faced a one-off, pre-tax loss of approximately $1.3 million due to an onerous contract identified during the period. Looking ahead, Coventry Group Limited has set an earnings guidance for FY26 with an expected EBITDA exceeding $20 million. The group is focused on a "back to basics" strategy, emphasizing sales growth, cost reduction, cash generation, debt reduction, and a significant improvement in financial performance. The Board is confident in the market opportunities and believes the team is well-positioned to execute these strategic goals. July sales were reported at $34 million, marking a 6.3% increase from June, indicating an improving run-rate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coventry Group Limited published the original content used to generate this news brief on August 05, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10